WP-1034, a novel Jak-Stat inhibitor, has proapoptotic and antileukemic activity in acute myeloid leukemia (AML) cell lines and AML patient samples.

被引:0
|
作者
Faderl, S
Ferrajoli, A
Harris, D
Van, Q
Priebe, W
Estrov, Z
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Dev Therapeut, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2528
引用
收藏
页码:693A / 693A
页数:1
相关论文
共 32 条
  • [31] THE D816V C-KIT MUTATION HAS HIGHER ABILITY OF JAK-STAT AND SRC FAMILY KINASE THAN N822K C-KIT MUTATION, AND THEREFORE PROLIFERATION ACTIVITY IS HIGH IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA
    Omori, I.
    Yamaguchi, H.
    Kitano, T.
    Miyake, N.
    Miyake, K.
    Kazuo, D.
    Inokuchi, K.
    HAEMATOLOGICA, 2015, 100 : 353 - 354
  • [32] Antileukemic Activity of 8-Chloro-Adenosine (8-Cl-Ado) Is Mediated By Mir-155 Degradation and ErbB3 Binding Protein (Ebp1)-Dependent p53 Activation: A Novel Therapeutic Approach for FLT3-ITD Acute Myeloid Leukemia (AML)
    Buettner, Ralf
    Le Xuan Truong Nguyen
    Kumar, Bijender
    Morales, Corey James
    Liu, Chao
    Chen, Lisa S.
    Pemovska, Tea
    Thompson, Ryan
    Li, Ling
    Dinh Hoa Hoang
    Zhang, Bin
    Ghoda, Lucy
    Kowolik, Claudia
    Kontro, Mika
    Wennerberg, Krister
    Leitch, Calum
    Yu, Xiaochun
    Chen, Ching-Cheng
    Horne, David
    Gandhi, Varsha
    Pullarkat, Vinod A.
    Marcucci, Guido
    Rosen, Steven T.
    BLOOD, 2018, 132